$AVNR News 4 stocks to watch 3:47 p.m. Sept. 1
Post# of 44991
Posted On: 09/22/2014 12:28:24 PM
$AVNR News
4 stocks to watch 3:47 p.m. Sept. 18, 2014 - The Trading Deck
5 companies that will benefit from ALS awareness 7:58 a.m. Aug. 22, 2014 - Jennifer Booton
U.S. stock futures cut rise after retail sales 8:53 a.m. Aug. 13, 2013 - Barbara Kollmeyer
Cree, Flowers Foods in focus Tuesday 8:42 a.m. Aug. 13, 2013 - Wallace Witkowski
Yum Brands shares drop on sour China sales 5:23 p.m. Aug. 12, 2013 - Wallace Witkowski
Avanir to promote Merck's diabetes drug Januvia 4:48 p.m. Aug. 12, 2013 - MarketWatch.com
Avanir shares rise after hours on license deal 6:29 p.m. July 2, 2013 - Wallace Witkowski
Avanir, OptiNose enter N. America licensing deal 5:27 p.m. July 2, 2013 - MarketWatch.com
7 gut checks before the stock market's opening bell 6:43 a.m. April 29, 2013 - Shawn Langlois
Avanir Pharmaceuticals shares down 3% 10:37 a.m. Nov. 17, 2010 - Nick Godt
Monday’s biggest gaining and declining stocks 5:25 p.m. Nov. 1, 2010 - Laura Mandaro
Avanir and Allergan lead drug stocks 1:55 p.m. Nov. 1, 2010 - Val Brickates Kennedy
Avanir leads drug stocks north 10:06 a.m. Nov. 1, 2010 - Val Brickates Kennedy
Rexahn, Avanir gain; Sequenom falls 1:32 p.m. April 7, 2010 - Val Brickates Kennedy
Avanir, Opexa gain ahead of presentations 3:16 p.m. April 6, 2010 - Val Brickates Kennedy
Avanir shares jump 10% in pre-market action 9:27 a.m. April 6, 2010 - Val Brickates Kennedy
Drug stocks pressured by J&J report; Avanir jumps 1:49 p.m. Oct. 13, 2009 - Val Brickates Kennedy
Avanir, Acorda move on MS drug updates 3:51 p.m. Oct. 9, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 6:10 p.m. Aug. 11, 2009 - MarketWatch
Avanir soars and Javelin sinks on drug studies 1:15 p.m. Aug. 11, 2009 - Val Brickates Kennedy
Weakness Seen in Avanir Pharmaceuticals (AVNR): Stock Falls 6.5% - Tale of the Tape 8:52 a.m. Sept. 19, 2014 - Zacks.com
Merck KGaA Teams Up with Sutro for ADCs Targeting Cancer - Analyst Blog 7:00 p.m. Sept. 18, 2014 - Zacks.com
Insider Trading Alert - RSG, HAL And AVNR Traded By Insiders 10:30 a.m. Sept. 18, 2014 - TheStreet.com
Biotech Stock Roundup: Avanir Soars on Phase II Data, Orexigen's Contrave Approved - Analyst Blog 3:00 p.m. Sept. 17, 2014 - Zacks.com
All Pop And No Sizzle Or Is Avanir Going Higher From Here? 9:30 a.m. Sept. 17, 2014 - Seeking Alpha
Merck KGaA-Lupin Ink Deal, Focus on Emerging Markets - Analyst Blog 4:14 p.m. Sept. 16, 2014 - Zacks.com
Avanir Pharmaceuticals Shoots Up on Positive AVP-923 Data - Analyst Blog 3:50 p.m. Sept. 16, 2014 - Zacks.com
AVANIR Pharmaceuticals (AVNR) Showing Signs Of Perilous Reversal Today 9:45 a.m. Sept. 16, 2014 - TheStreet.com
Is Avanir Pharma Fully Valued After Monday’s Rally? 9:13 a.m. Sept. 16, 2014 - 247WallSt.com
Benzinga's Top #PreMarket Losers 7:11 a.m. Sept. 16, 2014 - benzinga.com
Why Avanir Pharmaceuticals (AVNR) Stock Soared to a One-Year High Today 4:06 p.m. Sept. 15, 2014 - TheStreet.com
Merck KGaA Stops All Tecemotide Studies for Lung Cancer - Analyst Blog 3:42 p.m. Sept. 15, 2014 - Zacks.com
Terex Falls After Lowered Earnings Forecast; Avanir Pharmaceuticals Shares Surge 2:40 p.m. Sept. 15, 2014 - benzinga.com
Concert Pharma rides Avanir's coattails 1:30 p.m. Sept. 15, 2014 - Seeking Alpha
NASDAQ Tumbles 1.1%; Alere Shares Surge Following Proposed $46/Share Offer 12:24 p.m. Sept. 15, 2014 - benzinga.com
Midday Gainers From September 15 - RadioShack Corporation, Rewalk Robotics Ltd And More 11:32 a.m. Sept. 15, 2014 - benzinga.com
Alzheimer’s Study Results Take Avanir Back Up to Multiyear Highs 10:26 a.m. Sept. 15, 2014 - 247WallSt.com
Markets Fall; Cognizant To Acquire TriZetto For $2.7 Billion 10:26 a.m. Sept. 15, 2014 - benzinga.com
Morning Market Movers 8:42 a.m. Sept. 15, 2014 - benzinga.com
Biggest Movers in Healthcare Stocks Now – AVNR PTCT AZN HALO 8:30 a.m. Sept. 15, 2014 - InvestorPlace.com
Positive Study Results, Market Activity, Acquisition Proposal, Earnings Schedules, and Collaboration - Research Reports on Avanir, Jazz, Alere, Intuitive Surgical and GSK 9:05 a.m. Sept. 18, 2014 - PR Newswire - PRF
Critical Alerts For Yahoo!, El Pollo Loco, Avanir Pharmaceuticals, General Electric and Ballard Power Systems Released By InvestorsObserver 9:31 a.m. Sept. 16, 2014 - PR Newswire - PRF
Reveal Insider Trading for Yahoo, Apple, Facebook, Avanir Pharmaceuticals, Tesla Motors, and Twitter 8:55 a.m. Sept. 16, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Positive Phase II Trial Results for AVP-923 in Treatment of Agitation in Patients with Alzheimer's Disease 8:30 a.m. Sept. 15, 2014 - PR Newswire - PRF
Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma 9:25 a.m. Sept. 8, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference 9:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 9:00 a.m. Aug. 26, 2014 - PR Newswire - PRF
Technical Analysis on Pharma Equities -- Mylan, AVANIR Pharma, Horizon Pharma, VIVUS, and Auxilium Pharma 9:10 a.m. Aug. 6, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update 4:01 p.m. Aug. 5, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Date of Fiscal 2014 Third Quarter Financial Results and Conference Call 8:31 a.m. July 28, 2014 - GlobeNewswire
Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 9:15 a.m. July 21, 2014 - PR Newswire - PRF
Mark H.N. Corrigan, M.D., Julie H. McHugh, and William Hunter, M.D. to Serve on EPIRUS Board of Directors 11:50 a.m. July 15, 2014 - BusinessWire - BZX
Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals 5:10 a.m. July 14, 2014 - PR Newswire - PRF
Stocks Coverage on the Pharma Industry -- Research on Zoetis, Mylan, AVANIR Pharma, and Actavis 6:50 a.m. July 1, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Two Data Presentations Related to Pseudobulbar Affect (PBA) at the Alzheimer's Association International Conference (AAIC) 7:22 p.m. June 30, 2014 - PR Newswire - PRF
Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics 6:40 a.m. June 27, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Positive Outcome of Phase IIIb COMPASS Trial: A Head-to-Head Study Comparing AVP-825 to Oral Sumatriptan for the Acute Treatment of Migraine 4:00 a.m. June 10, 2014 - PR Newswire - PRF
Health Care Sector Equities Scrutiny -- Research on AVANIR Pharma, Zoetis, Actavis, and Mallinckrodt 7:50 a.m. June 3, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Completion of Patient Enrollment in Study of AVP-923 for the Treatment of Agitation in Patients with Alzheimer's Disease 9:00 a.m. May 27, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Reports Fiscal 2014 Second Quarter Financial and Business Results 4:01 p.m. May 6, 2014 - PR Newswire - PRF
4 stocks to watch 3:47 p.m. Sept. 18, 2014 - The Trading Deck
5 companies that will benefit from ALS awareness 7:58 a.m. Aug. 22, 2014 - Jennifer Booton
U.S. stock futures cut rise after retail sales 8:53 a.m. Aug. 13, 2013 - Barbara Kollmeyer
Cree, Flowers Foods in focus Tuesday 8:42 a.m. Aug. 13, 2013 - Wallace Witkowski
Yum Brands shares drop on sour China sales 5:23 p.m. Aug. 12, 2013 - Wallace Witkowski
Avanir to promote Merck's diabetes drug Januvia 4:48 p.m. Aug. 12, 2013 - MarketWatch.com
Avanir shares rise after hours on license deal 6:29 p.m. July 2, 2013 - Wallace Witkowski
Avanir, OptiNose enter N. America licensing deal 5:27 p.m. July 2, 2013 - MarketWatch.com
7 gut checks before the stock market's opening bell 6:43 a.m. April 29, 2013 - Shawn Langlois
Avanir Pharmaceuticals shares down 3% 10:37 a.m. Nov. 17, 2010 - Nick Godt
Monday’s biggest gaining and declining stocks 5:25 p.m. Nov. 1, 2010 - Laura Mandaro
Avanir and Allergan lead drug stocks 1:55 p.m. Nov. 1, 2010 - Val Brickates Kennedy
Avanir leads drug stocks north 10:06 a.m. Nov. 1, 2010 - Val Brickates Kennedy
Rexahn, Avanir gain; Sequenom falls 1:32 p.m. April 7, 2010 - Val Brickates Kennedy
Avanir, Opexa gain ahead of presentations 3:16 p.m. April 6, 2010 - Val Brickates Kennedy
Avanir shares jump 10% in pre-market action 9:27 a.m. April 6, 2010 - Val Brickates Kennedy
Drug stocks pressured by J&J report; Avanir jumps 1:49 p.m. Oct. 13, 2009 - Val Brickates Kennedy
Avanir, Acorda move on MS drug updates 3:51 p.m. Oct. 9, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 6:10 p.m. Aug. 11, 2009 - MarketWatch
Avanir soars and Javelin sinks on drug studies 1:15 p.m. Aug. 11, 2009 - Val Brickates Kennedy
Weakness Seen in Avanir Pharmaceuticals (AVNR): Stock Falls 6.5% - Tale of the Tape 8:52 a.m. Sept. 19, 2014 - Zacks.com
Merck KGaA Teams Up with Sutro for ADCs Targeting Cancer - Analyst Blog 7:00 p.m. Sept. 18, 2014 - Zacks.com
Insider Trading Alert - RSG, HAL And AVNR Traded By Insiders 10:30 a.m. Sept. 18, 2014 - TheStreet.com
Biotech Stock Roundup: Avanir Soars on Phase II Data, Orexigen's Contrave Approved - Analyst Blog 3:00 p.m. Sept. 17, 2014 - Zacks.com
All Pop And No Sizzle Or Is Avanir Going Higher From Here? 9:30 a.m. Sept. 17, 2014 - Seeking Alpha
Merck KGaA-Lupin Ink Deal, Focus on Emerging Markets - Analyst Blog 4:14 p.m. Sept. 16, 2014 - Zacks.com
Avanir Pharmaceuticals Shoots Up on Positive AVP-923 Data - Analyst Blog 3:50 p.m. Sept. 16, 2014 - Zacks.com
AVANIR Pharmaceuticals (AVNR) Showing Signs Of Perilous Reversal Today 9:45 a.m. Sept. 16, 2014 - TheStreet.com
Is Avanir Pharma Fully Valued After Monday’s Rally? 9:13 a.m. Sept. 16, 2014 - 247WallSt.com
Benzinga's Top #PreMarket Losers 7:11 a.m. Sept. 16, 2014 - benzinga.com
Why Avanir Pharmaceuticals (AVNR) Stock Soared to a One-Year High Today 4:06 p.m. Sept. 15, 2014 - TheStreet.com
Merck KGaA Stops All Tecemotide Studies for Lung Cancer - Analyst Blog 3:42 p.m. Sept. 15, 2014 - Zacks.com
Terex Falls After Lowered Earnings Forecast; Avanir Pharmaceuticals Shares Surge 2:40 p.m. Sept. 15, 2014 - benzinga.com
Concert Pharma rides Avanir's coattails 1:30 p.m. Sept. 15, 2014 - Seeking Alpha
NASDAQ Tumbles 1.1%; Alere Shares Surge Following Proposed $46/Share Offer 12:24 p.m. Sept. 15, 2014 - benzinga.com
Midday Gainers From September 15 - RadioShack Corporation, Rewalk Robotics Ltd And More 11:32 a.m. Sept. 15, 2014 - benzinga.com
Alzheimer’s Study Results Take Avanir Back Up to Multiyear Highs 10:26 a.m. Sept. 15, 2014 - 247WallSt.com
Markets Fall; Cognizant To Acquire TriZetto For $2.7 Billion 10:26 a.m. Sept. 15, 2014 - benzinga.com
Morning Market Movers 8:42 a.m. Sept. 15, 2014 - benzinga.com
Biggest Movers in Healthcare Stocks Now – AVNR PTCT AZN HALO 8:30 a.m. Sept. 15, 2014 - InvestorPlace.com
Positive Study Results, Market Activity, Acquisition Proposal, Earnings Schedules, and Collaboration - Research Reports on Avanir, Jazz, Alere, Intuitive Surgical and GSK 9:05 a.m. Sept. 18, 2014 - PR Newswire - PRF
Critical Alerts For Yahoo!, El Pollo Loco, Avanir Pharmaceuticals, General Electric and Ballard Power Systems Released By InvestorsObserver 9:31 a.m. Sept. 16, 2014 - PR Newswire - PRF
Reveal Insider Trading for Yahoo, Apple, Facebook, Avanir Pharmaceuticals, Tesla Motors, and Twitter 8:55 a.m. Sept. 16, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Positive Phase II Trial Results for AVP-923 in Treatment of Agitation in Patients with Alzheimer's Disease 8:30 a.m. Sept. 15, 2014 - PR Newswire - PRF
Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma 9:25 a.m. Sept. 8, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference 9:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 9:00 a.m. Aug. 26, 2014 - PR Newswire - PRF
Technical Analysis on Pharma Equities -- Mylan, AVANIR Pharma, Horizon Pharma, VIVUS, and Auxilium Pharma 9:10 a.m. Aug. 6, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update 4:01 p.m. Aug. 5, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Date of Fiscal 2014 Third Quarter Financial Results and Conference Call 8:31 a.m. July 28, 2014 - GlobeNewswire
Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 9:15 a.m. July 21, 2014 - PR Newswire - PRF
Mark H.N. Corrigan, M.D., Julie H. McHugh, and William Hunter, M.D. to Serve on EPIRUS Board of Directors 11:50 a.m. July 15, 2014 - BusinessWire - BZX
Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals 5:10 a.m. July 14, 2014 - PR Newswire - PRF
Stocks Coverage on the Pharma Industry -- Research on Zoetis, Mylan, AVANIR Pharma, and Actavis 6:50 a.m. July 1, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Two Data Presentations Related to Pseudobulbar Affect (PBA) at the Alzheimer's Association International Conference (AAIC) 7:22 p.m. June 30, 2014 - PR Newswire - PRF
Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics 6:40 a.m. June 27, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Positive Outcome of Phase IIIb COMPASS Trial: A Head-to-Head Study Comparing AVP-825 to Oral Sumatriptan for the Acute Treatment of Migraine 4:00 a.m. June 10, 2014 - PR Newswire - PRF
Health Care Sector Equities Scrutiny -- Research on AVANIR Pharma, Zoetis, Actavis, and Mallinckrodt 7:50 a.m. June 3, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Completion of Patient Enrollment in Study of AVP-923 for the Treatment of Agitation in Patients with Alzheimer's Disease 9:00 a.m. May 27, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Reports Fiscal 2014 Second Quarter Financial and Business Results 4:01 p.m. May 6, 2014 - PR Newswire - PRF
(0)
(0)